The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Equity Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.

Transactions / B•••••• H••••• S••••••••

A•••••• Completes B•••••• Acquisition; First Step to the Creation of a New Science- and Technology-Driven Value Demonstration Group

Platform acquisitionclosedannounced Feb 26, 2020closed Feb 26, 2020Fact
What happened
Platform
not an add-on on record
Control
Control
Share acquired
unknown
Industry
healthcare / pharma
Target location
unknown
Seller kind
unknown
Rollover
unknown
Values, only where disclosed
Enterprise value
Not disclosed
Purchase price
Not disclosed
Equity value
Not disclosed
Target revenue
Not disclosed
Target EBITDA
Not disclosed
Multiple
Not disclosed
Parties and roles
5 named
Buy side
  • G••• G••••••Deal partnerconfirmed
    G••• G••••••, an Investment Partner of A•••••• said, “A•••••• is building businesses to tackle some of healthcare’s most pressing challenges.
  • A•••••• Capital Partners (“A••••••”), a leading private equity firm investing in healthcare and specialty industrials companies, announced today the acquisition of B•••••• H••••• S•••••••• (“B••••••”), a pioneer in providing health economic research, communications, and consulting services to the gl
Advisory side
  • R•••• • G••• L••Legal adviserconfirmed
    R•••• • G••• L•• acted as a legal advisor to A••••••.
  • A••••••• P•••••••Sell-side adviserconfirmed
    A••••••• P••••••• served as the exclusive M&A advisor to B••••••; Keebles provided legal advice.
Side not stated
  • A•••••• Capital Partners (“A••••••”), a leading private equity firm investing in healthcare and specialty industrials companies, announced today the acquisition of B•••••• H••••• S•••••••• (“B••••••”), a pioneer in providing health economic research, communications, and consulting services to the gl
Evidence
A•••••• Capital Partners (“A••••••”), a leading private equity firm investing in healthcare and specialty industrials companies, announced today the acquisition of B•••••• H••••• S•••••••• (“B••••••”), a pioneer in providing health economic research, communications, and consulting services to the global pharmaceutical industry.